Literature DB >> 19021545

Iron chelation as a potential therapy for neurodegenerative disease.

Robert C Hider1, Yongmin Ma, Francisco Molina-Holgado, Alessandra Gaeta, Sourav Roy.   

Abstract

Neurodegenerative disorders include a variety of pathological conditions, which share similar critical metabolic processes such as protein aggregation and oxidative stress, both of which are associated with the involvement of metal ions. Chelation therapy could provide a valuable therapeutic approach to such disease states, since metals, particularly iron, are realistic pharmacological targets for the rational design of new therapeutic agents.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19021545     DOI: 10.1042/BST0361304

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  14 in total

Review 1.  Metals, oxidative stress and neurodegenerative disorders.

Authors:  Klaudia Jomova; Dagmar Vondrakova; Michael Lawson; Marian Valko
Journal:  Mol Cell Biochem       Date:  2010-08-22       Impact factor: 3.396

Review 2.  Synthetic and natural iron chelators: therapeutic potential and clinical use.

Authors:  Heather C Hatcher; Ravi N Singh; Frank M Torti; Suzy V Torti
Journal:  Future Med Chem       Date:  2009-12       Impact factor: 3.808

Review 3.  Redox control of prion and disease pathogenesis.

Authors:  Neena Singh; Ajay Singh; Dola Das; Maradumane L Mohan
Journal:  Antioxid Redox Signal       Date:  2010-06-01       Impact factor: 8.401

Review 4.  Iron-chelating backbone coupled with monoamine oxidase inhibitory moiety as novel pluripotential therapeutic agents for Alzheimer's disease: a tribute to Moussa Youdim.

Authors:  Orly Weinreb; Silvia Mandel; Orit Bar-Am; Tamar Amit
Journal:  J Neural Transm (Vienna)       Date:  2011-03-01       Impact factor: 3.575

5.  Combining conformational sampling and selection to identify the binding mode of zinc-bound amyloid peptides with bifunctional molecules.

Authors:  Liang Xu; Ke Gao; Chunyu Bao; Xicheng Wang
Journal:  J Comput Aided Mol Des       Date:  2012-07-25       Impact factor: 3.686

Review 6.  Mapping brain metals to evaluate therapies for neurodegenerative disease.

Authors:  Bogdan Florin Gh Popescu; Helen Nichol
Journal:  CNS Neurosci Ther       Date:  2010-06-14       Impact factor: 5.243

7.  Gender and iron genes may modify associations between brain iron and memory in healthy aging.

Authors:  George Bartzokis; Po H Lu; Kathleen Tingus; Douglas G Peters; Chetan P Amar; Todd A Tishler; J Paul Finn; Pablo Villablanca; Lori L Altshuler; Jim Mintz; Elizabeth Neely; James R Connor
Journal:  Neuropsychopharmacology       Date:  2011-03-09       Impact factor: 7.853

8.  Iron toxicity: new conditions continue to emerge.

Authors:  Eugene D Weinberg
Journal:  Oxid Med Cell Longev       Date:  2009 Apr-Jun       Impact factor: 6.543

9.  Prevalent iron metabolism gene variants associated with increased brain ferritin iron in healthy older men.

Authors:  George Bartzokis; Po H Lu; Todd A Tishler; Douglas G Peters; Anastasia Kosenko; Katherine A Barrall; J Paul Finn; Pablo Villablanca; Gerhard Laub; Lori L Altshuler; Daniel H Geschwind; Jim Mintz; Elizabeth Neely; James R Connor
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 10.  Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples.

Authors:  Douglas B Kell
Journal:  Arch Toxicol       Date:  2010-08-17       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.